John Hopkins’s study reveals blood cancer 3 years before diagnosis

Researchers from John Hopkins University say they revealed an advanced method for Cancer detection.

A new study published in the Journal Opening and partially funded by the National Institute of Health showed that the genetic material that is shed by tumors can be detected in the blood three years before A. Diagnosis of cancer.

Researchers have analyzed plasma samples from a major atherosclerosis risk study (ARIC) to assess heart attack factors, stroke, heart failure and other cardiovascular disease, the press release said.

FDA approves the first AI’s first tool for breast cancer risk

Blood samples were analyzed from 26 participants who were diagnosed with cancer for six months, and 26, which were not diagnosed with cancer.

Researchers have found that the genetic material shed by tumors can be detected in the blood three years before the diagnosis of cancer. (Istock)

Of these 52 participants, eight were positively recruited on a long -term cancer test (MCED) and were diagnosed with cancer within four months after blood collection.

MCED tests are an experimental type of cancer check that is simultaneously seeking signs of several types of cancer, according to the US Cancer Society. These signs may include pieces of DNA, RNA or proteins from abnormal cells.

Click here to subscribe to our health newsletter

For six of these eight individuals, the researchers were able to evaluate additional blood samples that were collected 3.1 to 3.5 years before the diagnosis.

In four samples, Researchers identified Mutations obtained by tumors (genetic changes in cancer cells).

“Three years earlier it gives time to interference,” the lead author said (not in the photo). (Istock)

He is the author of a leading study by Yuxyuan Van, Doctor of Medical Sciences, Associate Professor of the Department of Oncology at the University of John Hopkins Medical School, shared in a statement that investigators were surprised.

“Three years earlier it was time to intervene,” she said. ‘Tumors are likely to be much less advanced and most likely be healing“

For additional health articles visit www.foxnews.com/health

He is the author of the senior study, Bert Fogelstein, MD, Professor of Oncology Clayton and John Hopkins Center, said the study shows “the promise of MCED tests in the discovery of cancers very early, and sets the benchmark necessary for their success.”

Researchers analyzed plasma samples to assess the risk factors, stroke, heart failure and other cardiovascular disease. (Istock)

Detection of cancer over the years before clinical diagnosis can help “provide control more a favorable result“The senior author of Nicolas Padapulos, Professor of Oncology and the Investigative Center Ludwig, noted.

Click here to get the Fox News app

“Of course, we need to determine the appropriate clinical observation after a positive test on such rivers,” he added.

Fox News Digital addressed John Hopkins for comments.